CD8A and neoplasm: Given the limitations of current methods for identifying TR CD8 + TILs, we leveraged prior experience in using scRNA-seq combined with machine learning for the identification of tumor neoantigen-specific T cells [12] to develop a deep learning (DL) approach for identifying TR CD8 + TILs in pancreatic cancer.